Get started
DEXCOM INCDEXCOM INCDEXCOM INC

DEXCOM INC

No trades
See on Supercharts
Overview Financials News
Ideas
Discussions Technicals Forecast Seasonals Bonds

DXCM trade ideas

DexCom Pulls Back After an Earnings RallyDiabetes company DexCom has consolidated for about four months, and now it could be trying to move again. The first pattern on today’s chart is the bullish candle on February 10 after earnings beat estimates. It followed a similar rally on October 28, suggesting that investors are pleased with its fundamental performance. The earnings surge established DXCM above its 50-day simple moving average (SMA) and a trendline along the recent highs. Some traders may view that as a breakout. Next, MACD has been rising all month. Finally, the 50-day SMA had a “golden cross” above the 200-day SMA in November. Has the longer-term trend grown more bullish? TradeStation has, for decades, advanced the trading industry, providing access to stocks, options, futures and cryptocurrencies. See our Overview for more. Important Information TradeStation Securities, Inc., TradeStation Crypto, Inc., and TradeStation Technologies, Inc. are each wholly owned subsidiaries of TradeStation Group, Inc., all operating, and providing products and services, under the TradeStation brand and trademark. TradeStation Crypto, Inc. offers to self-directed investors and traders cryptocurrency brokerage services. It is neither licensed with the SEC or the CFTC nor is it a Member of NFA. When applying for, or purchasing, accounts, subscriptions, products, and services, it is important that you know which company you will be dealing with. Please click here for further important information explaining what this means. This content is for informational and educational purposes only. This is not a recommendation regarding any investment or investment strategy. Any opinions expressed herein are those of the author and do not represent the views or opinions of TradeStation or any of its affiliates. Investing involves risks. Past performance, whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. There is a possibility that you may sustain a loss equal to or greater than your entire investment regardless of which asset class you trade (equities, options, futures, or digital assets); therefore, you should not invest or risk money that you cannot afford to lose. Before trading any asset class, first read the relevant risk disclosure statements on the Important Documents page, found here: www.tradestation.com .
NASDAQ:DXCM
by TradeStation
2
DexCom to breakdown?DexCom - 30d expiry - We look to Sell a break of 108.48 (stop at 113.03) We are trading at overbought extremes. Although the bulls are in control, the stalling positive momentum indicates a turnaround is possible. A break of the recent low at 108.68 should result in a further move lower. This stock has seen poor sales growth. Levels above 122 continue to attract sellers. Our profit targets will be 97.11 and 95.11 Resistance: 118.00 / 120.00 / 125.55 Support: 108.68 / 105.00 / 100.00 Please be advised that the information presented on TradingView is provided to Vantage (‘Vantage Global Limited’, ‘we’) by a third-party provider (‘Signal Centre’). Please be reminded that you are solely responsible for the trading decisions on your account. There is a very high degree of risk involved in trading. Any information and/or content is intended entirely for research, educational and informational purposes only and does not constitute investment or consultation advice or investment strategy. The information is not tailored to the investment needs of any specific person and therefore does not involve a consideration of any of the investment objectives, financial situation or needs of any viewer that may receive it. Kindly also note that past performance is not a reliable indicator of future results. Actual results may differ materially from those anticipated in forward-looking or past performance statements. We assume no liability as to the accuracy or completeness of any of the information and/or content provided herein and the Company cannot be held responsible for any omission, mistake nor for any loss or damage including without limitation to any loss of profit which may arise from reliance on any information supplied by Signal Centre.
NASDAQ:DXCMShort
by VantageMarkets
Potential Uptrend in DexComDiabetes company DexCom has been fighting higher since June, and now it may be interesting to trend followers. The first pattern on today’s chart is the pair of bullish gaps last month. The initial rally came after the Centers for Medicare and Medicaid Services proposed expanding access to one of the company’s glucose-monitoring products. The second was triggered by strong quarterly results and guidance. Those jumps suggest a catalyst-driven uptrend could be taking shape. DXCM has consolidated for almost a month, and last week bounced near the low from its most recent gap. Has support been established at the higher level? Next, prices have held the rising 21-day exponential moving average (EMA). Additionally, the 50-day simple moving average (SMA) rose above the 200-day SMA on November 8. That “golden cross” could suggest its longer-term uptrend has turned positive again. Finally, stochastics are back to an oversold condition. TradeStation has, for decades, advanced the trading industry, providing access to stocks, options, futures and cryptocurrencies. See our Overview for more. Important Information TradeStation Securities, Inc., TradeStation Crypto, Inc., and TradeStation Technologies, Inc. are each wholly owned subsidiaries of TradeStation Group, Inc., all operating, and providing products and services, under the TradeStation brand and trademark. You Can Trade, Inc. is also a wholly owned subsidiary of TradeStation Group, Inc., operating under its own brand and trademarks. TradeStation Crypto, Inc. offers to self-directed investors and traders cryptocurrency brokerage services. It is neither licensed with the SEC or the CFTC nor is it a Member of NFA. When applying for, or purchasing, accounts, subscriptions, products, and services, it is important that you know which company you will be dealing with. Please click here for further important information explaining what this means. This content is for informational and educational purposes only. This is not a recommendation regarding any investment or investment strategy. Any opinions expressed herein are those of the author and do not represent the views or opinions of TradeStation or any of its affiliates. Investing involves risks. Past performance, whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. There is a possibility that you may sustain a loss equal to or greater than your entire investment regardless of which asset class you trade (equities, options, futures, or digital assets); therefore, you should not invest or risk money that you cannot afford to lose. Before trading any asset class, first read the relevant risk disclosure statements on the Important Documents page, found here: www.tradestation.com .
NASDAQ:DXCM
by TradeStation
1
DXCM: Bottom?DexCom Short Term - We look to Buy at 74.01 (stop at 60.52) A bullish reverse Head and Shoulders is forming. This is positive for sentiment and the uptrend has potential to return. There is scope for mild selling at the open but losses should be limited. Support is located at 70.00 and should stem dips to this area. Dip buying offers good risk/reward. Our profit targets will be 115.47 and 120.00 Resistance: 116.00 / 135.00 / 164.00 Support: 70.00 / 46.00 / 11.00 Please be advised that the information presented on TradingView is provided to Vantage (‘Vantage Global Limited’, ‘we’) by a third-party provider (‘Signal Centre’). Please be reminded that you are solely responsible for the trading decisions on your account. There is a very high degree of risk involved in trading. Any information and/or content is intended entirely for research, educational and informational purposes only and does not constitute investment or consultation advice or investment strategy. The information is not tailored to the investment needs of any specific person and therefore does not involve a consideration of any of the investment objectives, financial situation or needs of any viewer that may receive it. Kindly also note that past performance is not a reliable indicator of future results. Actual results may differ materially from those anticipated in forward-looking or past performance statements. We assume no liability as to the accuracy or completeness of any of the information and/or content provided herein and the Company cannot be held responsible for any omission, mistake nor for any loss or damage including without limitation to any loss of profit which may arise from reliance on any information supplied by Signal Centre.
NASDAQ:DXCMLong
by VantageMarkets
AB=CDIn this case, AB is equal to CD, which is ideal but not always the case.. You can use the magnet and move the AB leg to the CD position to see if it fits. This pattern when bullish, looks like a downtrend and is sometimes found within a larger downtrend, so be safe. The bearish version would begin with AB, or leg 1 to the upside. In the bullish version, the AB leg is downward as is the CD leg with an uptrace at the BC leg. The retracement (up-tracement leg BC)) can be between 38.2% to 78.6% of the A-B leg, however, an ideal pattern has a retracement of 61.8% to 78.6%. The ideal AB=CD pattern is equal in time and price, with point D being an Fibonacci extension between 127%-161.8% of the B-C leg. The pattern consists of three legs, with two equal legs labelled AB and CD, together they form a zig-zag shape. For this reason it is sometimes called the 'lightning bolt pattern'. Plenty of resistance overhead. The market has been tough and it does not seem to be a good idea to hang around too long. PE Ratio is high at 90.06. Short interest is around 3.78%. Earnings estimated to be July 28. Possible Stop below D or where you see support. DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM system for diabetes management; Dexcom Real-Time API, which enables invited third-party developers to integrate real-time CGM data into their digital health applications and devices; Dexcom ONE, that is designed to replace finger stick blood glucose testing for diabetes treatment decisions; and Dexcom Share, a remote monitoring system. The company’s products candidature comprises Dexcom G7, a next generation G7 CGM system. DexCom, Inc. has a collaboration and license agreement with Verily Life Sciences LLC and Verily Ireland Limited to develop blood-based or interstitial glucose monitoring products. The company markets its products directly to endocrinologists, physicians, and diabetes educators. DexCom, Inc. was incorporated in 1999 and is headquartered in San Diego, California. EPS (FWD) 3.31 PE (FWD) 90.06 **** Div Rate (FWD) Yield (FWD) Short Interest 3.78% Market Cap $28.37B Trade at your own risk/No recommendation
NASDAQ:DXCM
by lauralea
Why do fundamentals not matter?I am just writing this in all of about 2 seconds since I was reminded this morning but some clueless guy who wants to take a fundamental approach to investing. He really isn't. He is just trying to sound like he has a clue to what he is doing and in reality, he is getting beating like a baseball during a Red Sox/ Yankees world series. Dexcom... can anyone guess where its headed to? I think there is an obvious target for the retail crew don't really know how to chart. I think there is an even lower target below that though. It's why charting is important. Fundamentals are all good but they mean basically the stock 1) May not be de-listed 2) It may continue to make new highs. But when do you buy. How do you minimize your risk. Charts. There will always be a time to buy and when to sell and that's why fundamentals mean nothing. The chart will show you what the market thinks about the company long before you read a news article (which by the way, you should never do). Just look at the headlines, I happened to catch a few of them. The more honest people "The market still has a 25% drop to come" Inflation can be combated in two ways, much more aggressive fed action or crush the market to nothing". Then you have the scam artist fund people/ banks who .. ehh, I wont even repeat the crap they are saying. Never ever listen to the news. The chart is everything you need to know.. well and what makes the chart. Good luck to those that bought Dexcom at 700. I do like the company and think I will invest when it bottoms. They are becoming a force that is acquiring others. Reminds me of my days in the drug/ pharmaceutical sector. I worked for what is now the largest medical/ drug company in the world that started as a little pharmacist back in the 40s and now does billions a quarter. Love seeing companies grow like that as long as they dont step on my toes. lol. They just grew and bought anyone in their way. Literally. I like Dexcom and know they have a great reputation. Anyway, just know when to buy and thats why you need to know charts. Fundementals mean little except chances are the stock ticker will not be de-listed and the chances of higher highs are in your favor if you know when to get in.
NASDAQ:DXCM
by Original_Stock_Whisperer
2